ЭФФЕКТИВНОСТЬ ПРИМЕНЕНИЯ БТА ПРИ ЛЕЧЕНИИ БЛЕФАРОСПАЗМА
PDF

Як цитувати

Жураева, К., & Жураева, А. (2021). ЭФФЕКТИВНОСТЬ ПРИМЕНЕНИЯ БТА ПРИ ЛЕЧЕНИИ БЛЕФАРОСПАЗМА. InterConf, (45). вилучено із https://ojs.ukrlogos.in.ua/index.php/interconf/article/view/10328
PDF

Посилання

Anderson R.L., Patel B.C., Holds J.B., Jordan D.R. Blepharospasm: past, present, and future // Ophthal. Plast. Reconstr. Surg. 1998. Vol. 14, N 5. P. 305–317.

Borodic G.E., Cozzolino D. Blepharospasm and its treatment, with emphasis on the use of botulinum tox- in // Plast. Reconstr. Surg. 1989. Vol. 83, N 3. P. 546–554.

Carruthers J.D. Ophthalmologic use of botulinum A exotoxin // Can. J. Ophthalmol. 1985. Vol. 20, N 4. P. 135–141.

Dutton J.J., Buckley E.G. Botulinum toxin in the management of blepharospasm // Arch. Neurol. 1986. Vol. 43, N 4. P. 380–382.

Frueh B.R., Felt D.P., Wojno T.H., Musch D.C. Treatment of blepharospasm with botulinum toxin: a prelimi- nary report // Arch. Ophthalmol. 1984. Vol. 102, N 10. P. 1464–1468.

Jankovic J. Botulinum A toxin in the treatment of blepharospasm // Adv. Neurol. 1988. Vol. 49. P. 467–472.

Jordan D.R., Patrinely J.R., Anderson R.L., Thiese S.M. Essential blepharospasm and related dystonias // Surv. Ophthalmol. 1989. Vol. 34, N 2. P. 123–132. 7. McCann J.D., Ugurbas S.H., Goldberg R.A. Benign essential blepharospasm // Int. Ophthalmol. Clin. 2002. Vol. 42, N 2. P. 113–121.

Biglan A.W., May M., Bowers R.A. Management of facial spasm with Clostridium botulinumtoxin, type A

(Oculinum) // Arch. Otolaryngol. Head Neck Surg. 1988. Vol. 114, N 12. P. 1407–1412.

Brin M.F., Fahn S., Moskowitz C. et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm // Mov. Disord. 1987. Vol. 2, N 4. P. 237–254.

Chen R.S., Lu C.S., Tsai C.H. Botulinum toxin A injection in the treatment of hemifacial spasm // Acta Neurol. Scand. 1996. Vol. 94, N 3. P. 207–211.

Evidente V.G., Adler C.H. Hemifacial spasm and other craniofacial movement disorders // Mayo Clin. Proc. 1998. Vol. 73, N 1. P. 67–71.

Mauriello J.A. Jr, Leone T., Dhillon S. et al. Treatment choices of 119 patients with hemifacial spasm over 11 years // Clin. Neurol. Neurosurg. 1996. Vol. 98, N 3. P. 213–216.

Serrano L.A. The use of botulinum toxin type A for the treatment of facial spasm // Bol. Asoc. Med. P. R. 1993. Vol. 85, N 1–3. P. 7–11.

Tan E.K., Jankovic J. Bilateral hemifacial spasm: a report of five cases and a literature review // Mov. Disord. 1999. Vol. 14, N 2. P. 345–349.

Boghen D.R., Lesser R.L. Blepharospasm and hemifacial spasm // Curr. Treat. Options Neurol. 2000. Vol. 2, N 5. P. 393–400.

Cuevas C., Madrazo I., Magallon E. et al. Botulinum toxin A for the treatment of hemifacial spasm // Arch. Med. Res. 1995. Vol. 26, N 4. P. 405–408.

Defazio G., Abbruzzese G., Girlanda P. et al. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study // Arch. Neurol. 2002. Vol. 59, N 3. P. 418–420.

Digre K., Corbett J.J. Hemifacial spasm: differential diagnosis, mechanism, and treatment // Adv. Neurol. 1988. Vol. 49. P. 151–176.

Barker F.G. 2nd, Jannetta P.J., Bisonette D.J. et al. Microvascular decompression for hemifacial spasm // J.Neurosurg. 1995. Vol. 82. P. 201–210.

Blackburn M.K., Lamb R.D., Digre K.B. et al. FL-41 tint improves blink frequency, light sensitivity, and func-tional limitations in patients with benign essential blepharospasm // Ophthalmology. 2009. Vol. 116, N 5. P. 997–1001.

Creative Commons License

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.

Завантаження

Дані завантаження ще не доступні.

| Переглядів: 8 | Завантажень: 28 |